Search
for
Sort by
Research 361–390 of 1000+
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- No association between low-dose oral minoxidil and tachycardia in a large retrospective cohort study of patients with non-scarring alopecia
- Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice
- Alopecia areata
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- The pink tax: gender-based cost disparities of topical minoxidil
- No association between low-dose oral minoxidil and pericardial effusion in a large retrospective cohort study of nonscarring alopecia patients
- A guide to diagnosis and management of hypertrichosis
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Oral minoxidil for the treatment of late alopecia in cancer survivors.
- Biotin beware: Perils of biotin supplementation: Response to: “The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses. Part 2: B-complex vitamins”
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- No association between alcohol consumption and androgenetic alopecia: a nested case-control study
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Highlights from JAAD Reviews: Non-pharmacologic and adjunctive treatments for nail psoriasis and androgenetic alopecia
- More than cosmetic: A personal perspective on alopecia areata and therapeutic restoration
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Adjunctive Approaches for Androgenetic Alopecia: A Clinical Review of Nutritional, Light-Based, Topical, and Lifestyle Interventions
- No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients
- Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
- 61131 Impact of Low-Dose Oral Minoxidil on Blood Pressure in Androgenetic Alopecia Patients Concomitantly Taking Antihypertensive Medications: A Multi-Center Cohort Study
- Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
- Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss
- 0415 Spironolactone treatment for dermatologic conditions and blood pressure changes in hypertensive patients on concomitant antihypertensive therapy
- 0192 Estrogenic effects of 5-alpha-reductase inhibitors in male androgenetic alopecia patients
- Association Between Androgenetic Alopecia and Glucagon‐Like Peptide‐1 Receptor Treatment in Type 2 Diabetes Mellitus Patients: A Retrospective Cohort Study